Bavarian Nordic A/S (BAVA.CO)
Makes vaccines that protect against smallpox, monkeypox, rabies, and other serious diseases.
178.40+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-24.3%
The outlook
Bavarian Nordic trades near the lower end of its 52-week range and below both its 50- and 200-day moving averages, suggesting weakness in recent momentum. Analyst coverage points to an average price target roughly 50% above the current level, though the overall StockGlow score leans bearish. The stock's low trailing P/E of 11.8 reflects modest valuation relative to earnings.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +50% vs current price
Analyst price target
~12-month · 4 analysts267.50average target+49.9% vs now
Now 178.40
Low 250.00High 280.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$13.50B
52-wk high
244.80
52-wk low
171.30
50-day avg
184.07
200-day avg
193.21
Trailing P/E
11.8